Atopic Dermatitis

>

Latest News

Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color | Image Credit: © ltyuan - © ltyuan - stock.adobe.com.
Tapinarof cream 1% demonstrates efficacy in atopic dermatitis patients with skin of color

March 8th 2024

Data from a pair of identical, phase 3, double-blind, randomized, and vehicle-controlled trials were presented at the 2024 American Academy of Dermatology (AAD) Annual Meeting in San Diego, California.

Reaction to tapinarof cream, 1% sNDA submission with Lawrence Eichenfield, MD
Reaction to tapinarof cream, 1% sNDA submission with Lawrence Eichenfield, MD

February 15th 2024

Tapinarof cream, 1% sNDA filed to treat atopic dermatitis in patients 2 years and up | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
Dermavant submits sNDA for tapinarof cream, 1% to treat AD in patients 2 years and up

February 14th 2024

Weily Soong, MD | Author provided
A discussion of FDA-approved tralokinumab-ldrm for atopic dermatitis

January 26th 2024

Image Credit: Autur - stock.adobe.com.
Contemporary Pediatrics week in review: Roflumilast foam data, accidental firearm deaths in children, and more

January 19th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.